$FULC Fulcrum Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Fulcrum Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Fulcrum Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Fulcrum Therapeutics, Inc. for free.
CIK Number: 0001680581
IRS Number: 474839948
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: FULC
Company Address: 26 LANDSDOWNE STREET CAMBRIDGE 02139
Phone number: 617-651-8851
Fulcrum Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | FULC | Fulcrum Therapeuti ... | Stuart Bryan | See Remarks | Option Exercise | A | 11.78 | 350,000 | 4,123,000 | 350,000 | |
Mar 17 2021 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 12.43 | 789 | 9,806 | 506,630 | 507.4 K to 506.6 K (-0.16 %) |
Mar 17 2021 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 12.13 | 9,211 | 111,773 | 507,419 | 516.6 K to 507.4 K (-1.78 %) |
Feb 24 2021 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Option Exercise | M | 7.84 | 5,000 | 39,200 | 50,471 | |
Feb 24 2021 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 14.72 | 5,000 | 73,582 | 15,212 | 20.2 K to 15.2 K (-24.74 %) |
Feb 24 2021 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Buy | M | 7.84 | 5,000 | 39,200 | 20,212 | 15.2 K to 20.2 K (+32.87 %) |
Feb 04 2021 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Option Exercise | A | 11.33 | 269,390 | 3,052,189 | 269,390 | |
Jan 25 2021 | FULC | Fulcrum Therapeuti ... | Thomson Peter G. | VP Finance & Accoun ... | Sell | S | 14.00 | 6,607 | 92,498 | 15,212 | 21.8 K to 15.2 K (-30.28 %) |
Dec 07 2020 | FULC | Fulcrum Therapeuti ... | Ezekowitz Alan | Director | Option Exercise | A | 11.82 | 15,000 | 177,300 | 15,000 | |
Sep 14 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | M | 7.84 | 6,350 | 49,784 | 75,592 | |
Sep 14 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Buy | M | 7.84 | 6,350 | 49,784 | 133,438 | 127.1 K to 133.4 K (+5.00 %) |
Jul 09 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Option Exercise | M | 7.84 | 2,951 | 23,136 | 81,942 | |
Jul 09 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Sell | S | 20.00 | 2,951 | 59,020 | 127,088 | 130 K to 127.1 K (-2.27 %) |
Jul 09 2020 | FULC | Fulcrum Therapeuti ... | Wallace Owen B. | Chief Scientific Of ... | Buy | M | 7.84 | 2,951 | 23,136 | 130,039 | 127.1 K to 130 K (+2.32 %) |
Jul 09 2020 | FULC | Fulcrum Therapeuti ... | Gould Robert J | See Remarks | Sell | S | 20.00 | 2,500 | 50,000 | 534,845 | 537.3 K to 534.8 K (-0.47 %) |